Scolaris Content Display Scolaris Content Display

Cochrane Database of Systematic Reviews Protocol - Intervention

Methods for cervical ripening and labour induction in late pregnancy: generic protocol

Collapse all Expand all

Abstract

This is a protocol for a Cochrane Review (Intervention). The objectives are as follows:

To determine, from the best available evidence, the effectiveness and safety of induction agents or procedures for third trimester cervical ripening and induction of labour.

Background

Induction of labour

Induction of labour may be considered beneficial in many clinical circumstances. These include fetal growth restriction (or other states of potential fetal compromise), spontaneous rupture of membranes, pre‐eclampsia, and post‐term pregnancy. The effects of induction of labour in some specific clinical situations are assessed in other Cochrane reviews (e.g. Boulvain 2001a; Gülmezoglu 2006; Irion 1999).

A review of the evidence‐base for labour induction indications found that recommendations for induction of labour for post‐term gestation, premature rupture of membranes at term, and premature rupture of membranes near term with pulmonary maturity are supported by evidence; induction for fetal growth impairment before term reduces intrauterine fetal death, but increases caesarean deliveries and neonatal deaths; evidence is insufficient to support induction for women with insulin‐requiring diabetes, twin gestation, fetal macrosomia, oligohydramnios, cholestasis of pregnancy, maternal cardiac disease and fetal gastroschisis (Mozurkewich 2009).  On the other hand, risk‐guided preventive labour induction is claimed to improve birth outcomes (Nicholson 2009). Labour induction, for clinical indications, if performed, usually takes place during the third trimester of pregnancy (after 28 weeks).

Labour may also be induced for social reasons, e.g., to coincide with planned leave from work by the woman or her partner (Crosby 2008).  Labour induction tends to be more common in women who live far from obstetric services (Kornelsen 2009).

Recently, emphasis has been placed on the value of avoiding elective delivery before 39 weeks’ gestation due to increased rates of neonatal high care admissions (Clark 2009). A specific program to reduce early term elective deliveries has been found to be effective (Oshiro 2009), as has labour induction guidelines backed by medical staff education (Fisch 2009).

Labour induction in the evening (for example, at about 2100 hours) has been found to be associated with similar labour duration and improved neonatal outcome than that commenced in the morning (Bakker 2009).

Methods for inducing labour

When a woman and her caregivers agree that labour induction is necessary (or desirable), the best method of induction needs to be chosen. The main problems experienced during induction of labour are an inability to achieve effective labour, or the production of excessively strong uterine contractions. The latter may cause both maternal and fetal distress, and both problems may lead to an increased risk of caesarean section. Excessive uterine activity, through inappropriate use of uterine stimulants, may occasionally lead to the very serious complication of uterine rupture (and fetal death).

There is considerable variation in how women perceive induction of labour. At one end of the continuum are women who dislike the idea of induction intensely. At the other end of the continuum are women who welcome interventions to bring the birth of their baby forward. Whilst there are legitimate reasons to debate what is a desirable rate of induction of labour in any population of pregnant women, and whether in some settings this rate is much higher than it should be, that is not the objective of this protocol and its daughter reviews. These focus specifically on methods, not use and abuse.

There are several clinical factors which may influence the choice of induction method. These include parity, the condition of the cervix, membrane status, and presence or absence of a uterine scar (usually from a previous caesarean section).

Parity is important because women tend to be more sensitive (and sometimes much more sensitive) to stimulatory drugs if they have had a baby (or babies) previously. In a recent observational study, nulliparous women with an undilated cervix whose labours were electively induced had a 50% caesarean section rate (Clark 2009).

The state of the woman's cervix can be assessed by vaginal examination and 'scored' (Bishop 1964) to make a semi‐quantitative prediction of 'favourability' for labour induction. Induction tends to be easier if the cervix is soft, dilated, and short (favourable/high cervical score) and more difficult if firm, closed and long (unfavourable/low cervical score). When the cervix is unfavourable, prostaglandin preparations are often used (Keirse 1993; MacKenzie 1997) although these may be particularly associated with uterine hyperstimulation (Egarter 1990). More recently, ultrasound measurements of cervical length and distance from the perineum to the baby’s head have been suggested as additional parameters for assessment of cervical readiness (Eggebø 2009). Ultrasound measurement of cervical length and body mass index were found to be better predictors of caesarean section than the clinical cervical score (Uyar 2009).

Women whose membranes have already ruptured may respond differently to stimulatory drugs than those whose membranes are still intact at the time of labour induction. The drainage of amniotic fluid through the vagina may also flush out locally applied medication. The presence of a uterine scar carries a risk of dehiscence during labour, especially if uterine activity is excessive. Though uncommon, this is potentially a very serious complication that can pose a threat to the lives of both baby and mother.

There are many methods of labour induction that include administration of oxytocin; prostaglandins; prostaglandin analogues and smooth muscle stimulants, such as herbs or castor oil; or mechanical methods, such as digital stretching of the cervix and sweeping of the membranes; hygroscopic cervical dilators; extra‐amniotic balloon catheters; artificial rupture of the membranes; and nipple stimulation. Acupuncture and homeopathy have also been used. Because of the scale of this topic and the multiplicity of trials comparing one method with others and the potential for duplication of effort, members of the Cochrane Pregnancy and Childbirth Group decided to address this subject strategically. We developed a common methodology and panel of outcome measures for all labour induction reviews. In addition, we devised a strategy whereby each comparison has a single 'home' review (e.g., comparison of mifepristone versus vaginal misoprostol would appear only in the mifepristone review ‐ seeData collection and analysis).

We decided to combine techniques that aim to ripen the cervix (make it more soft, short and open) and those that aim to induce labour. As mentioned above, prostaglandins are frequently used to ripen the cervix when it is 'unfavourable' but this commonly causes labour to start. We therefore felt that the distinction between ripening and labour induction is, in practice, artificial.

This protocol forms the basis of a series of reviews of methods of labour induction ‐ seeMethods for more detailed information. It differs from other protocols published in The Cochrane Library because it will be retained permanently as a protocol to describe the methods that shaped the production of all labour induction reviews, unlike other Cochrane protocols which usually develop into full reviews. In addition to the general background in this generic protocol, each of the individual induction of labour reviews will include its own method‐specific background information.

Objectives

To determine, from the best available evidence, the effectiveness and safety of induction agents or procedures for third trimester cervical ripening and induction of labour.

Methods

Criteria for considering studies for this review

Types of studies

Clinical trials comparing any method of third trimester cervical ripening or labour induction, with placebo/no treatment or other methods; the trials should include some form of random allocation to either group; and they should report one or more of the prestated outcomes.

Types of participants

Pregnant women due for third trimester induction of labour, carrying a viable fetus.

Types of interventions

All methods of third trimester cervical ripening or labour induction compared with placebo/no treatment or any other method.

Types of outcome measures

Clinically relevant outcomes for trials of methods of cervical ripening/labour induction have been prespecified by two authors of labour induction reviews (Justus Hofmeyr and Zarko Alfirevic). We settled differences by discussion.

Primary outcomes

Five primary outcomes were chosen as being most representative of the clinically important measures of effectiveness and complications:
(1) vaginal delivery not achieved within 24 hours (or period specified by trial authors);
(2) uterine hyperstimulation with fetal heart rate (FHR) changes;
(3) caesarean section;
(4) serious neonatal morbidity or perinatal death (e.g., seizures, birth asphyxia defined by trialists, neonatal encephalopathy, disability in childhood);
(5) serious maternal morbidity or death (e.g., uterine rupture, admission to intensive care unit, septicaemia).

Perinatal and maternal morbidity and mortality are composite outcomes. This is not an ideal solution because some components are clearly less severe than others. It is possible for one intervention to cause more deaths but less severe morbidity. However, in the context of labour induction at term this is unlikely. All of these events will be rare, and a modest change in their incidence will be easier to detect if composite outcomes are presented. The incidence of individual components will be explored as secondary outcomes (see below).

Secondary outcomes

Secondary outcomes relate to measures of effectiveness, complications and satisfaction.

Measures of effectiveness

(6) cervix unfavourable/unchanged after 12 to 24 hours;
(7) oxytocin augmentation.

Complications

(8) uterine hyperstimulation without FHR changes;
(9) uterine rupture;
(10) epidural analgesia;
(11) instrumental vaginal delivery;
(12) meconium‐stained liquor;
(13) Apgar score less than seven at five minutes;
(14) neonatal intensive care unit admission;
(15) neonatal encephalopathy;
(16) perinatal death;
(17) disability in childhood;
(18) maternal side‐effects (all);
(19) maternal nausea;
(20) maternal vomiting;
(21) maternal diarrhoea;
(22) other maternal side‐effects;
(23) postpartum haemorrhage (as defined by the trial authors);
(24) serious maternal complications (e.g., intensive care unit admission, septicaemia but excluding uterine rupture);
(25) maternal death.

Measures of satisfaction

(26) woman not satisfied;
(27) caregiver not satisfied.

'Uterine rupture' will include all clinically significant ruptures of unscarred or scarred uteri. Trivial scar dehiscence noted incidentally at the time of surgery will be excluded.

Additional outcomes may appear in individual reviews.

While all the above outcomes will be sought, only those with data will appear in the analysis tables.

The terminology of uterine hyperstimulation is problematic (Curtis 1987). In the reviews we will use the term 'uterine hyperstimulation without FHR changes' to include uterine tachysystole (more than five contractions per 10 minutes for at least 20 minutes) and uterine hypersystole/hypertonus (a contraction lasting at least two minutes) and 'uterine hyperstimulation with FHR changes' to denote uterine hyperstimulation syndrome (tachysystole or hypersystole with fetal heart rate changes such as persistent decelerations, tachycardia or decreased short term variability).

Outcomes will be included in the analysis: if reasonable measures were taken to minimise observer bias; and data were available for analysis according to original allocation.

In more recent reviews and updates the following outcomes have been added:(28) neonatal infection;
(29) neonatal antibiotics;
(30) chorioamnionitis;
(31) endometritis;
(32) maternal antibiotics.

Search methods for identification of studies

The search methods for identification of studies will be set out in each review.

Data collection and analysis

To avoid duplication of data the labour induction methods have been listed in a specific order, from one to 27. Each review includes comparisons between one of the methods (from two to 27) with only those methods above it on the list. Thus, the review of intravenous oxytocin (4) will include only comparisons with intracervical prostaglandins (3), vaginal prostaglandins (2) or placebo (1). Methods identified in the future will be added to the end of the list. The current list is as follows:

  1. placebo/no treatment;

  2. vaginal prostaglandins (Kelly 2003);

  3. intracervical prostaglandins (Boulvain 2008);

  4. intravenous oxytocin (Kelly 2001c);

  5. amniotomy (Bricker 2000);

  6. intravenous oxytocin with amniotomy (Howarth 2001);

  7. vaginal misoprostol (Hofmeyr 2003);

  8. oral misoprostol (Alfirevic 2006);

  9. mechanical methods including extra‐amniotic Foley catheter (Boulvain 2001b);

  10. membrane sweeping (Boulvain 2005);

  11. extra‐amniotic prostaglandins (Hutton 2001);

  12. intravenous prostaglandins (Luckas 2000);

  13. oral prostaglandins (French 2001);

  14. mifepristone (Neilson 2000);

  15. estrogens (Thomas 2001);

  16. corticosteroids (Kavanagh 2006a);

  17. relaxin (Kelly 2001a);

  18. hyaluronidase (Kavanagh 2006b);

  19. castor oil, bath, and/or enema (Kelly 2001b);

  20. acupuncture (Smith 2004);

  21. breast stimulation (Kavanagh 2005);

  22. sexual intercourse (Kavanagh 2001);

  23. homoeopathic methods (Smith 2003);

  24. nitric oxide (Kelly 2008)

  25. buccal or sublingual misoprostol (Muzonzini 2004);

  26. hypnosis;

  27. other methods for induction of labour.

The reviews will be analysed by the following clinical categories of participants:

  1. previous caesarean section or not;

  2. nulliparity or multiparity;

  3. membranes intact or ruptured;

  4. cervix favourable, unfavourable or undefined.

For most reviews, the initial data extraction process was conducted centrally. This was co‐ordinated from the Clinical Effectiveness Support Unit (CESU) at the Royal College of Obstetricians and Gynaecologists, UK, in co‐operation with the Pregnancy and Childbirth Group of the Cochrane Collaboration. This process allowed the data extraction process to be standardised across all the reviews. From 2001, the data extraction was no longer conducted centrally.

The trials were initially reviewed on eligibility criteria, using a standardised form and the basic selection criteria specified above. Following this, a standardised data extraction form was developed and then piloted for consistency and completeness. This pilot process involved the researchers at the CESU and previous review authors in the area of induction of labour. For a description of the methods used to carry out the initial reviews, seeAppendix 1 and Appendix 2.

In 2008 the methods and software for carrying out reviews were updated, as a result of which new reviews and updates, where appropriate, will use these new methods (Higgins 2008; RevMan 2008), which will be described in the Methods section of all the individual new and updated reviews.